EHAB (Enhabit) ROCE % : -32.13% (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Enhabit ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Enhabit's annualized ROCE % for the quarter that ended in Sep. 2024 was -32.13%.

Enhabit ROCE % Historical Data

The historical data trend for Enhabit's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enhabit ROCE % Chart

Enhabit Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

7.07

9.65

-0.71

-3.52

Enhabit Quarterly Data
	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial												2.42	1.51	3.98	3.48	-32.13

Enhabit ROCE % Calculation

Enhabit's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-47.4	/	( ( (1526.8 - 132.9)	+	(1433.6 - 137.7) )	/ 2 )
	=	-47.4	/	( (1393.9	+	1295.9)	/ 2 )
	=	-47.4	/	1344.9
	=	-3.52 %

Enhabit's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-392	/	( ( (1419 - 140.1)	+	(1304.3 - 142.9) )	/ 2 )
	=	-392	/	( ( 1278.9	+	1161.4 )	/ 2 )
	=	-392	/	1220.15
	=	-32.13 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Enhabit (NYSE:EHAB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Enhabit ROCE % Related Terms

Thank you for viewing the detailed overview of Enhabit's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Enhabit Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Enhabit Inc (NYSE:EHAB) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

X34:Germany

Address

6688 North Central Expressway, Suite 1300, Dallas, TX, USA, 75206

Website

https://www.ehab.com

Enhabit Inc provides home health and hospice services in the United States. It offers care where patients prefer it: in their homes. It operates business in two segments: home health and hospice. Its home health segment include a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates the majority of its revenue from the Home Health segment.

Executives

Jeffrey Bolton	director	1016 CIVIC CENTER DRIVE NW, ROCHESTER MN 55901
Erin Hoeflinger	director	511 FALLVIEW COURT, SPRINGBORO OH 45066
Langham Ronald Leroy Jr	officer: EVP Clinical Excel. & Strategy	6688 CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Shaw L Edward Jr	director	AETNA INC, 151 FARMINGTON AVE RC4B, HARTFORD CT 06156
Stuart M Mcguigan	director	74 AGAMENTICUS AVENUE, CAPE NEDDICK ME 03902
Barry P. Schochet	director	100 EAST RIVERCENTER BLVD, 16TH FLOOR, COVINGTON KY 41011
Dylan C Black	officer: General Counsel and Secretary	6688 CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Higdon Leo I Jr	director	1700 LINCOLN STREET, 28TH FLOOR, DENVER CO 80203
Gregory S Rush	director	TEKELEC, 26580 W. AGOURA RD., CALABASAS CA 91302
Tina L. Brown-stevenson	director	6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Tanya Renee Marion	officer: Chief Human Resources Officer	6688 NORTH CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Charles M Elson	director	1401 61STG STREET S, STETSON UNIV COLLEGE OF LAW, ST PETERSBURG FL 33707
Barbara Ann Jacobsmeyer	director, officer: President and CEO	2122 ACTON PARK WAY, BIRMINGHAM AL 35243
Yvonne M Curl	director	C/O ENHABIT, INC., 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Maupin John E Jr D D S	director	103 POWELL COURT SUITE 200, BRENTWOOD TN 37027